Imprivata, an IT security company focused on healthcare, has announced the launch of a new electronic medical prescription platform. Imprivata Confirm ID is now available for medical professionals to prescribe controlled substances digitally, allowing for greater efficiency and reliability of documentation and records-keeping.
The new platform can be integrated with electronic health records and uses a two-factor authentication process that has been approved by the DEA. That process entails the use of fingerprint identification in conjunction with one-time-password tokens, and it allows medical professionals to provide a consistent e-signature for all electronic prescriptions. Speaking in a press release, Imprivata CEO Omar Hussein pointed to the many drawbacks of the rising use of paper-based prescriptions, including “clinical workflow inefficiencies” and “decreasing patient satisfaction”, and noted that Imprivata Confirm ID provides “a comprehensive, integrated product that simplifies the adoption of regulatory requirements for EPCS [Electronic Prescribing of Controlled Substances] and enables fast, secure e-prescribing of controlled substances.”
Healthcare work is increasingly digital as medical professionals and patients alike adopt new technologies to track and share health statistics – for example, the Drchrono app allows medical professionals to electronically access patient records via their iPhones’ TouchID fingerprint-scanning authentication, while immediate access to electronic records (again via biometric technology) could soon save lives at the front lines of on-site medical treatment as paramedics start to use myLife-Touch devices. As more and more of these digital records emerge, it only makes sense that medical professionals will continue to turn to electronic prescriptions to keep in step.
—
February 9, 2015 – by Alex Perala
Follow Us